Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.

[1]  W. Roser Reproducibility of metabolite peak areas in 1H MRS of the human brain. , 1997, Magnetic resonance imaging.

[2]  B J Soher,et al.  Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference , 1996, Magnetic resonance in medicine.

[3]  H C Charles,et al.  Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain , 1996, Magnetic resonance in medicine.

[4]  I. Marshall,et al.  Reproducibility of metabolite peak areas in 1H MRS of brain. , 1996, Magnetic resonance imaging.

[5]  G J Barker,et al.  Simulation of MRI cluster plots and application to neurological segmentation. , 1996, Magnetic resonance imaging.

[6]  R. Bryan,et al.  Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. , 1995, AJR. American journal of roentgenology.

[7]  M. McLean,et al.  Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. , 1995, Stroke.

[8]  D G Gadian,et al.  N-acetylaspartate and epilepsy. , 1995, Magnetic resonance imaging.

[9]  F Cendes,et al.  Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy. , 1995, Magnetic resonance imaging.

[10]  O Henriksen,et al.  Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites , 1994, NMR in biomedicine.

[11]  M Xue,et al.  Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. , 1994, Radiology.

[12]  D. Gadian,et al.  Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.

[13]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[14]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[15]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[16]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[17]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[18]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[19]  G. Fein,et al.  Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.

[20]  S. Morikawa,et al.  Proton magnetic resonance spectroscopy with dementia. , 1993, Surgical neurology.

[21]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[22]  H. Larsson,et al.  The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.

[23]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[24]  A. J. Kumar,et al.  Proton NMR spectroscopy of Canavan's disease. , 1992, Neuropediatrics.

[25]  J. Frahm,et al.  On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro , 1992, NMR in biomedicine.

[26]  J. Hennig,et al.  Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy , 1992, NMR in biomedicine.

[27]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[28]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[29]  B D Ross,et al.  Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. , 1992, Radiology.

[30]  J. Olesen,et al.  Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis , 1991, Magnetic resonance in medicine.

[31]  J. Frahm,et al.  Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.

[32]  D. Gadian,et al.  Localized 1H NMR spectroscopy in Canavan's Disease: A report of two cases , 1991, Magnetic resonance in medicine.

[33]  D. Gadian,et al.  Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis , 1991, The Lancet.

[34]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[35]  R. Kreis,et al.  Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy , 1990, The Lancet.

[36]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[37]  W. Grodd,et al.  In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy , 1990, The Lancet.

[38]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.

[39]  Ad Bax,et al.  Improved solvent suppression in one-and two-dimensional NMR spectra by convolution of time-domain data , 1989 .

[40]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[41]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[42]  T. Bohan,et al.  Regional in vivo proton magnetic resonance spectroscopy of brain , 1989 .

[43]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[44]  Keith R Thulborn,et al.  Absolute molar concentrations by NMR in inhomogeneous B1. A scheme for analysis of in vivo metabolites , 1983 .

[45]  I. Jensen,et al.  TEMPORAL LOBE EPILEPSY , 1976, Acta Neurochirurgica.